EASD 2024: The Impacts of Automated Insulin Delivery and CGMs
This week, T1D Exchange attended the 60th European Association for the Study of Diabetes (EASD) Annual Meeting in Madrid, Spain….
Strategies to Increase the Use of Connected Insulin Pens Through Shared Decision-Making: A Quality Improvement Success Story
Friedman, J, Silberman, P, Hermann, S, Aleppo, G Quality Improvement Success Stories are published by the American Diabetes Association in…
Increasing Access to Connected Insulin Pens by Promoting Shared Decision-Making Through Collaborative Quality Improvement
Friedman, J, Odugbesan, O, Ebekozien, O, Aleppo, G The T1D Exchange Quality Improvement Collaborative (T1DX-QI) is a multicenter initiative that…
Partnering With Families Through Shared Decision-Making to Increase Connected Pen Use: A Quality Improvement Success Story
Adams, B, Heston, A, Davis, D, Nelson, G Quality Improvement Success Stories are published by the American Diabetes Association in…
Increasing Awareness and Uptake of Connected Insulin Pens for Eligible Patients With Diabetes: A Quality Improvement Success Story
He, V.L, Shin, N, Shaghasi, H, Tsai, S Quality Improvement Success Stories are published by the American Diabetes Association in…
Depression Rates in Youth With Type 1 Diabetes During the COVID-19 Pandemic: Data From the T1D Exchange Quality Improvement Collaborative
Roberts, A, Corathers, S, Rapaport, R, Rompicherla, S, Majidi, S, Rioles, N, Ebekozien, O, Malik, F This study used data…
Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
Phillip, M, et.al Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage…
Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Demeterco-Berggren, C, Jacobsen, L, Guttmann-Bauman, I, Ospelt, E, Smego, A, Hannon, T, Aleppo, G, Chouhary, A, Wong, J, Ebekozien, O…
Multiple Daily Injection (MDI) to Automated Insulin Delivery (AID) vs. Non-AID Insulin Pump for Newly Diagnosed People with Type 1 Diabetes Offers Improvement in Glycemic Control
Rompicherla, S, Miller, K, Chao, L, Akturk, H.K, Alonso, G.T, Davis, G, DeSalvo, D, Weinstock, R, Hsieh, S, Kamboj, M,…
Understanding Off-Label Use of GLP-1 (Glucagon-Like Peptide-1 Receptor) Agonists among Providers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Gallagher, M.P, Basina, M, Ospelt, E, Rioles, N, Breidbart, E, Zupa, M, Eng, D, Ng, J, Levy, C, Ebekozien, O…
